XML 103 R47.htm IDEA: XBRL DOCUMENT
v3.22.4

Acquisitions and Strategic Investments (Details) |  |  |  |  |  |  | 2 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 29, 2022 USD ($) | Jun. 15, 2022 USD ($) | Jun. 15, 2022 KRW (₩) | Nov. 08, 2021 USD ($) | Sep. 01, 2021 USD ($) | Aug. 06, 2021 USD ($) | Mar. 01, 2021 USD ($) | Feb. 23, 2023 USD ($) | Feb. 23, 2023 KRW (₩) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | Feb. 20, 2023
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from disposal of certain businesses and assets |  |  |  |  |  |  |  |  |  | $ 5,000,000 | $ 826,000,000 | $ 15,000,000 |
Business Combination, Contingent Consideration, Liability |  |  |  |  |  |  |  |  |  | 149,000,000 | 486,000,000 | 196,000,000 |
Goodwill |  |  |  |  |  |  |  |  |  | 12,920,000,000 | 11,988,000,000 | 9,951,000,000 |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  |  |  |  |  |  | 1,542,000,000 | 2,258,000,000 | 3,000,000 |
Fair value of contingent consideration |  |  |  |  |  |  |  |  |  | (149,000,000) | (486,000,000) | (196,000,000) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases |  |  |  |  |  |  |  |  |  | 0 | 440,000,000 | 0 |
Intangible asset impairment charges |  |  |  |  |  |  |  |  |  | 132,000,000 | 370,000,000 | 460,000,000 |
Contingent consideration net expense (benefit) |  |  |  |  |  |  |  |  |  | 35,000,000 | (136,000,000) | (100,000,000) |
Payment of contingent consideration |  |  |  |  |  |  |  |  |  | 371,000,000 | 15,000,000 |  |
Goodwill impairment charges |  |  |  |  |  |  |  |  |  | 0 | $ 0 | $ 73,000,000 |
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Disposal Group, Including Discontinued Operation, Consideration |  |  |  |  |  |  | $ 800,000,000 |  |  |  |  |  |
Divestiture, agreement, transfer of facilities |  |  |  |  |  |  | 5 |  |  |  |  |  |
Divestiture, agreement, transfer of global employees |  |  |  |  |  |  | 280 |  |  |  |  |  |
Preventice Solutions, Inc. [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration, Liability |  |  |  |  |  |  |  |  |  | 221,000,000 |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value |  |  |  |  |  |  |  |  |  | 269,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |  |  |  |  |  |  |  |  |  | 1,197,000,000 |  |  |
Goodwill |  |  |  |  |  |  |  |  |  | 926,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | 237,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets |  |  |  |  |  |  |  |  |  | 0 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |  |  |  |  |  |  |  |  |  | 65,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |  |  |  |  |  |  |  |  |  | (32,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities |  |  |  |  |  |  |  |  |  | 0 |  |  |
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination |  |  |  |  |  |  | $ 925,000,000 |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage |  |  |  |  |  |  | 22.00% |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill |  |  |  |  |  |  |  |  |  | 237,000,000 |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  |  |  |  |  |  | $ 216,000,000 |  |  |  |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  |  |  | 706,000,000 |  |  | 706,000,000 |  |  |
Fair value of contingent consideration |  |  |  |  |  |  |  |  |  | (221,000,000) |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain |  |  |  |  |  |  | 196,000,000 |  |  |  |  |  |
Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest |  |  |  |  |  |  | $ 300,000,000 |  |  |  |  |  |
Preventice Solutions, Inc. [Member] | Technology-Based Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 215,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 9 years |  |  |
Preventice Solutions, Inc. [Member] | Technology-Based Intangible Assets [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 10.00% |  |  |
Preventice Solutions, Inc. [Member] | Other Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 22,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 8 years |  |  |
Preventice Solutions, Inc. [Member] | Other Intangible Assets [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 10.00% |  |  |
Farapulse, Inc. |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination |  |  |  |  |  | $ 450,000,000 |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage |  |  |  |  |  | 27.00% |  |  |  |  |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  |  |  |  |  | $ 92,000,000 |  |  |  |  |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  |  | 268,000,000 |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain |  |  |  |  |  | 222,000,000 |  |  |  |  |  |  |
Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest |  |  |  |  |  | $ 125,000,000 |  |  |  |  |  |  |
Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items] |  |  |  |  |  | 3 years |  |  |  |  |  |  |
Lumenis LTD |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration, Liability |  |  |  |  |  |  |  |  |  | $ 0 |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value |  |  |  |  |  |  |  |  |  | 0 |  |  |
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |  |  |  |  |  |  |  |  |  | 1,032,000,000 |  |  |
Goodwill |  |  |  |  |  |  |  |  |  | 534,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | 423,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets |  |  |  |  |  |  |  |  |  | 69,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |  |  |  |  |  |  |  |  |  | 297,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |  |  |  |  |  |  |  |  |  | (282,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities |  |  |  |  |  |  |  |  |  | (9,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill |  |  |  |  |  |  |  |  |  | 492,000,000 |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  | $ 1,032,000,000.000 |  |  |  |  | 1,032,000,000 |  |  |
Fair value of contingent consideration |  |  |  |  |  |  |  |  |  | 0 |  |  |
Accrued Income Taxes, Noncurrent |  |  |  |  |  |  |  |  |  | 183,000,000 |  |  |
Business Combination, Indemnification Assets, Amount as of Acquisition Date |  |  |  |  |  |  |  |  |  | 177,000,000 |  |  |
Lumenis LTD | In Process Research and Development [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 69,000,000 |  |  |
Lumenis LTD | In Process Research and Development [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 12.00% |  |  |
Lumenis LTD | Technology-Based Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 388,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 12 years |  |  |
Lumenis LTD | Technology-Based Intangible Assets [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 11.00% |  |  |
Lumenis LTD | Other Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 35,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 11 years |  |  |
Lumenis LTD | Other Intangible Assets [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 11.00% |  |  |
Devoro Medical, Inc. |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination |  |  |  | $ 320,000,000 |  |  |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage |  |  |  | 16.00% |  |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  |  |  | $ 67,000,000 |  |  |  |  |  |  |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  | 251,000,000 |  |  |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain |  |  |  | 57,000,000 |  |  |  |  |  |  |  |  |
Business combination, contingent consideration arrangements, range of outcomes, value, high, including prior interest |  |  |  | $ 80,000,000 |  |  |  |  |  |  |  |  |
All Other 2021 Acquisitions |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration, Liability |  |  |  |  |  |  |  |  |  | $ 218,000,000 |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value |  |  |  |  |  |  |  |  |  | 287,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |  |  |  |  |  |  |  |  |  | 1,025,000,000 |  |  |
Goodwill |  |  |  |  |  |  |  |  |  | 594,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | 465,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets |  |  |  |  |  |  |  |  |  | 43,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |  |  |  |  |  |  |  |  |  | 9,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |  |  |  |  |  |  |  |  |  | (11,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities |  |  |  |  |  |  |  |  |  | (75,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill |  |  |  |  |  |  |  |  |  | 508,000,000 |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  |  |  |  |  |  | 519,000,000 |  |  |
Fair value of contingent consideration |  |  |  |  |  |  |  |  |  | (218,000,000) |  |  |
All Other 2021 Acquisitions | In Process Research and Development [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 43,000,000 |  |  |
All Other 2021 Acquisitions | In Process Research and Development [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 17.00% |  |  |
All Other 2021 Acquisitions | Technology-Based Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 465,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 12 years |  |  |
All Other 2021 Acquisitions | Technology-Based Intangible Assets [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 16.00% |  |  |
All Other 2021 Acquisitions | Technology-Based Intangible Assets [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 17.00% |  |  |
2021 Acquisitions |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Contingent Consideration, Liability |  |  |  |  |  |  |  |  |  | $ 440,000,000 |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value |  |  |  |  |  |  |  |  |  | 556,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |  |  |  |  |  |  |  |  |  | 3,254,000,000 |  |  |
Goodwill |  |  |  |  |  |  |  |  |  | 2,053,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | 1,125,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets |  |  |  |  |  |  |  |  |  | 112,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |  |  |  |  |  |  |  |  |  | 372,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |  |  |  |  |  |  |  |  |  | (325,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities |  |  |  |  |  |  |  |  |  | (84,000,000) |  |  |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High |  |  |  |  |  |  |  |  |  | 417,000,000 |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  |  |  |  |  |  | 2,258,000,000 |  |  |
Fair value of contingent consideration |  |  |  |  |  |  |  |  |  | (440,000,000) |  |  |
Baylis Medical |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |  |  |  |  |  |  |  |  |  | 1,463,000,000 |  |  |
Goodwill |  |  |  |  |  |  |  |  |  | 988,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | 657,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |  |  |  |  |  |  |  |  |  | 112,000,000 |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |  |  |  |  |  |  |  |  |  | (287,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities |  |  |  |  |  |  |  |  |  | (7,000,000) |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill |  |  |  |  |  |  |  |  |  | 657,000,000 |  |  |
Payments to Acquire Businesses, Net of Cash Acquired |  |  |  |  |  |  |  |  |  | 1,463,000,000 |  |  |
Baylis Medical | Technology-Based Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 622,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 11 years |  |  |
Baylis Medical | Technology-Based Intangible Assets [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 11.00% |  |  |
Baylis Medical | Other Intangible Assets [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |  |  |  |  |  |  |  |  |  | $ 36,000,000 |  |  |
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life |  |  |  |  |  |  |  |  |  | 11 years |  |  |
Baylis Medical | Other Intangible Assets [Member] | Weighted Average (Member) |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Discount Rate, Fair Value Input |  |  |  |  |  |  |  |  |  | 11.00% |  |  |
M.I. Tech Co., Ltd |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | $ 615,000,000 | $ 230,000,000 | ₩ 291,200,000,000 |  |  |  |  |  |  |  |  |  |
Business Acquisition, Percentage of Voting Interests Acquired |  | 64.00% | 64.00% |  |  |  |  |  |  |  |  |  |
M.I. Tech Co., Ltd | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | ₩ |  |  |  |  |  |  |  |  | ₩ 20.00 |  |  |  |
Acotec Scientific Holdings Limited | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value |  |  |  |  |  |  |  | $ 520,000,000 |  |  |  |  |
Business Acquisition, Percentage of Voting Interests Acquired |  |  |  |  |  |  |  |  |  |  |  |  | 65.00%
Apollo Endosurgery, Inc. |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | $ 10.00 |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition, Percentage of Voting Interests Acquired | 100.00% |  |  |  |  |  |  |  |  |  |  |  |
Farapulse |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Payment of contingent consideration |  |  |  |  |  |  |  |  |  | $ 114,000,000 |  |  |

X
- Definition Business Combination, Consideration Transferred, Additional Revenue Payment, period [Line Items] + References No definition available. + Details
Name: | bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentPeriod
Namespace Prefix: | bsx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest + References No definition available. + Details
Name: | bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
Namespace Prefix: | bsx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Discount Rate, Fair Value Input + References No definition available. + Details
Name: | bsx_DiscountRateFairValueInput
Namespace Prefix: | bsx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Divestiture, agreement, transfer of facilities + References No definition available. + Details
Name: | bsx_DivestitureAgreementTransferOfFacilities
Namespace Prefix: | bsx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Divestiture, agreement, transfer of global employees + References No definition available. + Details
Name: | bsx_DivestitureAgreementTransferOfGlobalEmployees
Namespace Prefix: | bsx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Payment of contingent consideration + References No definition available. + Details
Name: | bsx_PaymentOfContingentConsideration
Namespace Prefix: | bsx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(15)(b)(1)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(15)(1)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccruedIncomeTaxesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to, instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of liabilities assumed at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g)(1) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination. + References No definition available. + Details
Name: | us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation. + References No definition available. + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinesses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_PreventiceSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_FarapulseIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_DevoroMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_AllOther2021AcquisitionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_A2021AcquisitionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_BaylisMedicalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_MITechCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_AcotecScientificHoldingsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_ApolloEndosurgeryIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bsx_FarapulseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |